in

Sudan: U.S. sanctions over alleged chemical weapons use come into force

Sudan: U.S. sanctions over alleged chemical weapons use come into force

Sudanese General Abdel-Fattah Burhan, head of the military council, cleans his eye of dust during an army-backed rally in Omdurman district, Sudan, Saturday, June 29, 2019
  –  

Copyright © africanews

Hussein Malla/Copyright 2019 The AP. All rights reserved.

By Africanews

Last updated:
29/06 – 11:36

Civil War

The sanctions – which include restrictions on US exports, arms sales and financial assistance to Sudan will stay in place for at least a year.

Only humanitarian assistance will not be affected by the sanctions.

Sudan’s army leader General Abdel Fattah al Burhan and his former deputy and Rapid Support Forces (RSF) chief Mohamed Dagalo are already sanctioned by the US.

The latest embargo was prompted by allegations of chemical weapons use by Sudan’s military in operations against RSF fighters.

Citing anonymous US officials, the New York Times reported in January that government soldiers deployed chlorine gas, known to cause severe respiratory pain and death, in military operations.

Sudanese officials denied the accusation.

A power struggle between Sudan’s army rulers in 2023 plunged the country into a brutal civil war which has killed tens of thousands.

The conflict has displaced 13 million people, creating what the United Nations describes as the world’s worst humanitarian crisis.

You may also like

Most read

What do you think?

Newbie

Written by Buzzapp Master

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

    South Africa: ANC partner quits key govt initiative as new spat hits coalition

    South Africa: ANC partner quits key govt initiative as new spat hits coalition

    Using testosterone gel to treat women recovering from hip fractures provides no added benefits, clinical trial finds

    Using testosterone gel to treat women recovering from hip fractures provides no added benefits, clinical trial finds